SG11202004591YA - Method and device for discriminating between viral and bacterial infections - Google Patents
Method and device for discriminating between viral and bacterial infectionsInfo
- Publication number
- SG11202004591YA SG11202004591YA SG11202004591YA SG11202004591YA SG11202004591YA SG 11202004591Y A SG11202004591Y A SG 11202004591YA SG 11202004591Y A SG11202004591Y A SG 11202004591YA SG 11202004591Y A SG11202004591Y A SG 11202004591YA SG 11202004591Y A SG11202004591Y A SG 11202004591YA
- Authority
- SG
- Singapore
- Prior art keywords
- discriminating
- viral
- bacterial infections
- infections
- bacterial
- Prior art date
Links
- 208000035143 Bacterial infection Diseases 0.000 title 1
- 208000036142 Viral infection Diseases 0.000 title 1
- 208000022362 bacterial infectious disease Diseases 0.000 title 1
- 230000003612 virological effect Effects 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
- G01N33/54387—Immunochromatographic test strips
- G01N33/54388—Immunochromatographic test strips based on lateral flow
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4715—Cytokine-induced proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4737—C-reactive protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP17203120.5A EP3489686B1 (en) | 2017-11-22 | 2017-11-22 | Method and device for discriminating between viral and bacterial infections |
PCT/EP2018/062466 WO2019101370A1 (en) | 2017-11-22 | 2018-05-15 | Method and device for discriminating between viral and bacterial infections |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202004591YA true SG11202004591YA (en) | 2020-06-29 |
Family
ID=60661707
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202004591YA SG11202004591YA (en) | 2017-11-22 | 2018-05-15 | Method and device for discriminating between viral and bacterial infections |
Country Status (29)
Country | Link |
---|---|
US (2) | US20200371095A1 (en) |
EP (1) | EP3489686B1 (en) |
JP (1) | JP6961101B2 (en) |
KR (1) | KR102330236B1 (en) |
CN (1) | CN111656191B (en) |
AU (1) | AU2018373176A1 (en) |
BR (1) | BR112020010245A2 (en) |
CA (1) | CA3083305A1 (en) |
CL (1) | CL2020001359A1 (en) |
CO (1) | CO2020006252A2 (en) |
CU (1) | CU24620B1 (en) |
CY (1) | CY1124005T1 (en) |
DK (1) | DK3489686T3 (en) |
EA (1) | EA202091301A1 (en) |
ES (1) | ES2851798T3 (en) |
HR (1) | HRP20210495T1 (en) |
HU (1) | HUE054089T2 (en) |
IL (1) | IL274768B2 (en) |
LT (1) | LT3489686T (en) |
MA (1) | MA50113B1 (en) |
MX (1) | MX2020005340A (en) |
PL (1) | PL3489686T3 (en) |
PT (1) | PT3489686T (en) |
RS (1) | RS61621B1 (en) |
SA (1) | SA520412020B1 (en) |
SG (1) | SG11202004591YA (en) |
SI (1) | SI3489686T1 (en) |
UA (1) | UA125669C2 (en) |
WO (1) | WO2019101370A1 (en) |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994021280A1 (en) * | 1993-03-22 | 1994-09-29 | Incyte Pharmaceuticals, Inc. | Use of bactericidal/permeability increasing protein and lipopolysaccharide binding protein levels and ratios thereof in diagnosis |
EP0937254B1 (en) * | 1996-10-31 | 2007-05-23 | Peter Von Wussow | Monoclonal antibody directed against MxA and MxB |
EP1110970B1 (en) * | 1999-12-22 | 2008-05-14 | Dade Behring Marburg GmbH | Anti-Procalcitonin antibodies, their production and use |
EP1552021A4 (en) * | 2002-06-11 | 2006-06-14 | Idaho Res Foundation | Type i interferon-inducible proteins to detect viral infection |
US7300802B2 (en) * | 2003-04-25 | 2007-11-27 | Biodigit Laboratories Corp. | Membrane strip biosensor system for point-of-care testing |
US8614101B2 (en) | 2008-05-20 | 2013-12-24 | Rapid Pathogen Screening, Inc. | In situ lysis of cells in lateral flow immunoassays |
WO2007082259A2 (en) * | 2006-01-11 | 2007-07-19 | The University Of Wyoming | Surrogate markers for viral infections and other inflammatory responses |
WO2008024642A2 (en) * | 2006-08-11 | 2008-02-28 | Baylor Research Institute | Gene expression signatures in blood leukocytes permit differential diagnosis of acute infections |
US9910036B2 (en) * | 2008-05-20 | 2018-03-06 | Rapid Pathogen Screening, Inc. | Method and device for combined detection of viral and bacterial infections |
KR102130186B1 (en) * | 2013-03-07 | 2020-07-06 | 레피드 페써겐 스크리닝, 아이엔씨. | Multiplanar lateral flow assay with diverting zone |
DE102015100845A1 (en) | 2015-01-21 | 2016-07-21 | Gottfried Wilhelm Leibniz Universität Hannover | Optical sensor system |
CN105242049A (en) * | 2015-09-15 | 2016-01-13 | 安云庆 | Kit for discriminating and diagnosing acute mycoplasma, bacteria and virus infection and application thereof |
-
2017
- 2017-11-22 RS RS20210358A patent/RS61621B1/en unknown
- 2017-11-22 SI SI201730662T patent/SI3489686T1/en unknown
- 2017-11-22 LT LTEP17203120.5T patent/LT3489686T/en unknown
- 2017-11-22 HU HUE17203120A patent/HUE054089T2/en unknown
- 2017-11-22 ES ES17203120T patent/ES2851798T3/en active Active
- 2017-11-22 EP EP17203120.5A patent/EP3489686B1/en active Active
- 2017-11-22 PL PL17203120T patent/PL3489686T3/en unknown
- 2017-11-22 PT PT172031205T patent/PT3489686T/en unknown
- 2017-11-22 DK DK17203120.5T patent/DK3489686T3/en active
-
2018
- 2018-05-15 EA EA202091301A patent/EA202091301A1/en unknown
- 2018-05-15 AU AU2018373176A patent/AU2018373176A1/en active Pending
- 2018-05-15 JP JP2020545857A patent/JP6961101B2/en active Active
- 2018-05-15 US US16/766,337 patent/US20200371095A1/en not_active Abandoned
- 2018-05-15 CU CU2020000043A patent/CU24620B1/en unknown
- 2018-05-15 UA UAA202003675A patent/UA125669C2/en unknown
- 2018-05-15 MX MX2020005340A patent/MX2020005340A/en unknown
- 2018-05-15 CN CN201880085879.0A patent/CN111656191B/en active Active
- 2018-05-15 IL IL274768A patent/IL274768B2/en unknown
- 2018-05-15 CA CA3083305A patent/CA3083305A1/en active Pending
- 2018-05-15 SG SG11202004591YA patent/SG11202004591YA/en unknown
- 2018-05-15 WO PCT/EP2018/062466 patent/WO2019101370A1/en active Application Filing
- 2018-05-15 BR BR112020010245-8A patent/BR112020010245A2/en unknown
- 2018-05-15 KR KR1020207017824A patent/KR102330236B1/en active IP Right Grant
- 2018-05-15 MA MA50113A patent/MA50113B1/en unknown
-
2020
- 2020-05-21 SA SA520412020A patent/SA520412020B1/en unknown
- 2020-05-22 CL CL2020001359A patent/CL2020001359A1/en unknown
- 2020-05-22 CO CONC2020/0006252A patent/CO2020006252A2/en unknown
-
2021
- 2021-03-26 HR HRP20210495TT patent/HRP20210495T1/en unknown
- 2021-03-26 CY CY20211100271T patent/CY1124005T1/en unknown
-
2022
- 2022-08-26 US US17/897,026 patent/US20220404346A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL261529A (en) | Rna determinants for distinguishing between bacterial and viral infections | |
EP3637325A4 (en) | Processing method and accelerating device | |
EP3591912A4 (en) | Evpn packet processing method, device and system | |
EP3588872A4 (en) | Evpn packet processing method, device and system | |
EP3493491A4 (en) | Packet forwarding method and device | |
EP3471347A4 (en) | Vxlan packet processing method, device and system | |
EP3223481A4 (en) | Packet processing method and device | |
EP3309993A4 (en) | Method, device and system for processing vxlan packet | |
EP3482200A4 (en) | Protein signatures for distinguishing between bacterial and viral infections | |
EP3343846A4 (en) | Method, device and system for processing packet | |
EP3301870A4 (en) | Route processing method, device and system | |
EP3255603A4 (en) | Image processing device, image processing system, and image processing method | |
EP3285477A4 (en) | Image processing device, image processing method, and image processing system | |
EP3454557A4 (en) | Image processing device, and image processing method | |
EP3285476A4 (en) | Image processing device, image processing method, and image processing system | |
EP3325624A4 (en) | Methods for detecting and treating low-virulence infections | |
EP3416039A4 (en) | Image processing device, image processing system, and image processing method | |
IL262765A (en) | System and method for treating bacterial infection | |
EP3217608A4 (en) | Switchback delay method, device, and system | |
EP3148164A4 (en) | Packet processing method and device | |
EP3437003A4 (en) | System and method employing reduced time device processing | |
EP3292962A4 (en) | Suction device, holding device, and conveyance method | |
EP3393153A4 (en) | Method and device for processing packets | |
EP3606282A4 (en) | Congestion processing method and device | |
EP3416361A4 (en) | Image processing device, image processing system and image processing method |